Doxorubicin-induced myocardial injury [2] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 18, 2004, Pages 1908-1909

  Fujisaki, George ^a   Inokuchi, Chiho ^a   Murashige, Naoko ^a   Lipshultz, Steven E ^b   Silverman, Lewis B ^c   Sallan, Stephen E ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; RAZOXANE; ANTINEOPLASTIC ANTIBIOTIC; CARDIOVASCULAR AGENT;

BONE MARROW SUPPRESSION; CLINICAL TRIAL; DRUG EFFECT; DRUG FATALITY; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; LETTER; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RANDOMIZATION; ACUTE LYMPHOCYTIC LEUKEMIA; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; NOTE; REMISSION;

ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; DISEASE-FREE SURVIVAL; DOXORUBICIN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; RAZOXANE; REMISSION INDUCTION;

EID: 7044234660     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200410283511819     Document Type: Letter

References (0)